Cargando…

COVID‐19 Vaccine Response in People with Multiple Sclerosis

OBJECTIVE: The purpose of this study was to investigate the effect of disease modifying therapies on immune response to severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) vaccines in people with multiple sclerosis (MS). METHODS: Four hundred seventy‐three people with MS provided one or mor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tallantyre, Emma C., Vickaryous, Nicola, Anderson, Valerie, Asardag, Aliye Nazli, Baker, David, Bestwick, Jonathan, Bramhall, Kath, Chance, Randy, Evangelou, Nikos, George, Katila, Giovannoni, Gavin, Godkin, Andrew, Grant, Leanne, Harding, Katharine E., Hibbert, Aimee, Ingram, Gillian, Jones, Meleri, Kang, Angray S., Loveless, Samantha, Moat, Stuart J., Robertson, Neil P., Schmierer, Klaus, Scurr, Martin J., Shah, Sita Navin, Simmons, Jessica, Upcott, Matthew, Willis, Mark, Jolles, Stephen, Dobson, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652739/ https://www.ncbi.nlm.nih.gov/pubmed/34687063 http://dx.doi.org/10.1002/ana.26251

Ejemplares similares

Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
por: Tallantyre, Emma C, et al.
Publicado: (2022)

Detecting and predicting neutralization of alemtuzumab responses in MS
por: Saxena, Gauri, et al.
Publicado: (2020)

A cell-based assay for the detection of neutralizing antibodies against alemtuzumab
por: Ali, Liaqat, et al.
Publicado: (2020)

GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains
por: Saxena, Gauri K., et al.
Publicado: (2020)

The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
por: Baker, David, et al.
Publicado: (2020)

The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies
por: Baker, David, et al.
Publicado: (2020)

CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis
por: Baker, David, et al.
Publicado: (2022)

The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination
por: Baker, David, et al.
Publicado: (2023)

Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case Report
por: Bradley, Rachel E., et al.
Publicado: (2021)

MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses – Commentary
por: Schmierer, K, et al.
Publicado: (2021)

Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study
por: Papathanasiou, Athanasios, et al.
Publicado: (2023)

Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies
por: Beesley, R., et al.
Publicado: (2022)

T‐cell modulation by cyclophosphamide for tumour therapy
por: Hughes, Ellyn, et al.
Publicado: (2018)

Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
por: Baker, David, et al.
Publicado: (2017)

Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom
por: Kuri, Ashvin, et al.
Publicado: (2020)

Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
por: Tallantyre, E. C., et al.
Publicado: (2018)

Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
por: Tallantyre, E. C., et al.
Publicado: (2018)

Resolution of persistent SARS-CoV-2 infection with prolonged intravenous remdesivir and vaccination in a patient post CAR-T
por: Ambati, Sai, et al.
Publicado: (2023)

In Vitro Evaluation of Frozen-Thawed Stallion Semen: A Review
por: Katila, T
Publicado: (2001)

Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study
por: Jacobs, Benjamin Meir, et al.
Publicado: (2021)

Toward a Disease-Modifying Therapy of Alpha-Synucleinopathies: New Molecules and New Approaches Came into the Limelight
por: Upcott, Matthew, et al.
Publicado: (2021)

Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens
por: Moat, Stuart J, et al.
Publicado: (2020)

Remote testing of vitamin D levels across the UK MS population—A case control study
por: Vickaryous, Nicola, et al.
Publicado: (2020)

Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing Scheme
por: Giovannoni, G, et al.
Publicado: (2019)

Subtle motor disturbances in PREDICT-PD participants
por: Noyce, Alastair J, et al.
Publicado: (2017)

The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis
por: Adams, Ashok, et al.
Publicado: (2022)

Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells
por: Thomson, Amanda, et al.
Publicado: (2021)

A Risk Score for Predicting Multiple Sclerosis
por: Dobson, Ruth, et al.
Publicado: (2016)

Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis
por: Alvarez‐Gonzalez, Cesar, et al.
Publicado: (2017)

Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial
por: Topcu, Gogem, et al.
Publicado: (2022)

Cognate peptide-receptor ligand mapping by directed phage display
por: Stratmann, Thomas, et al.
Publicado: (2005)

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis
por: Hares, Kelly, et al.
Publicado: (2021)

What palliative care–related problems do patients with drug-resistant or drug-susceptible tuberculosis experience on admission to hospital? A cross-sectional self-report study
por: Harding, Richard, et al.
Publicado: (2016)

Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant women
por: Moat, Stuart J., et al.
Publicado: (2022)

Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?
por: Mateo-Casas, M., et al.
Publicado: (2020)

COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases
por: Baker, D., et al.
Publicado: (2020)

Radial Glia and Neuronal-like Ependymal Cells Are Present within the Spinal Cord of the Trunk (Body) in the Leopard Gecko (Eublepharis macularius)
por: Donato, Sarah V., et al.
Publicado: (2022)

Assessing the Prognostic Value of Preoperative Carcinoembryonic Antigen-Specific T-Cell Responses in Colorectal Cancer
por: Scurr, Martin J., et al.
Publicado: (2015)

Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease
por: Noyce, Alastair J, et al.
Publicado: (2012)

Bradykinesia-Akinesia Incoordination Test: Validating an Online Keyboard Test of Upper Limb Function
por: Noyce, Alastair J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_765u5pfntpfqps1cjtl3a4ccl2